1De Eilde J,Spiers R,Mertens C,et al.A double2blind comparative,multicentre study comparing paroxetine with fluoxetine in depressed pa2 tients[J].Acta Psychiatr Scand,1993,87:141.
2Konig F,yon Hippel C,Petersdorff T,et at.First experiences in com2 bination therapy using olanzapine with SSRIs(citatopram,paroxetine)in delusional depression[J].Neuropsychobiology,2001,43(3):170.
3Ostroff RB,Nelson JC.Risperidone augmentation of selective serotonin reuptake inhihitors in major depression[J].J Clin Psychiatry,1999,60(4):256.
4Rocca P,Fonzo V,Scotta M,et al.Paroxetine efficacy in the treatment of generalized anxiety disorder[J].Acts Psychiatr Scand,1997,95:444.
5Markowitz JS,DeVane CL,Liston HL,et al.An assessment of selective serotonin reuptake inhibitor discontinuation symptoms with citalopram[J].Int Clin Psychopharmacol,2000,15(6):329.
6Fontaine R,Ontiveros A,Elie R,et at.A double2blind comparison of nefazodone,imiprsmine,and placebo in major depression[J].J Clin Psychiatry,1994,55(6):234.
7Joumat of psychiatry,2010,vol23,No.3.
8Clerc GE,Ruimy P,Verdeau2Pailles J.A double2blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia[J].Int Clin Psychopharmacol,1994,9:139.
9Bremner JD,Smith WT.Org 3880 vs Amitfiptyline in the continuation treatment of depression:a placebo controlled trial[J].Eur J Psychia2 try,1996,10(1):5.
10Leinonen E,Skarstein J,Behnke K,et al.Effecacy and tolerability of mirtazapine versus citalopram:a double2blind,randomized study in pa2 tients with major depressive disorder[J].Int Clin Psychopharmacol,1999,14:329.
